LifeStance Health Group, Inc. (NASDAQ:LFST) Shares Bought by Victory Capital Management Inc.

Victory Capital Management Inc. lifted its position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) by 2,599.0% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 370,598 shares of the company’s stock after purchasing an additional 356,867 shares during the period. Victory Capital Management Inc. owned about 0.10% of LifeStance Health Group worth $2,468,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in LFST. Janus Henderson Group PLC lifted its stake in LifeStance Health Group by 51.4% in the fourth quarter. Janus Henderson Group PLC now owns 59,500 shares of the company’s stock valued at $439,000 after buying an additional 20,200 shares during the last quarter. Northern Trust Corp increased its holdings in shares of LifeStance Health Group by 11.7% in the 4th quarter. Northern Trust Corp now owns 1,591,776 shares of the company’s stock valued at $11,731,000 after acquiring an additional 166,731 shares during the period. Geode Capital Management LLC raised its position in LifeStance Health Group by 0.4% in the 4th quarter. Geode Capital Management LLC now owns 3,465,471 shares of the company’s stock valued at $25,546,000 after purchasing an additional 13,293 shares during the last quarter. Wellington Management Group LLP boosted its stake in LifeStance Health Group by 9.2% during the 4th quarter. Wellington Management Group LLP now owns 5,276,237 shares of the company’s stock worth $38,886,000 after purchasing an additional 445,796 shares during the period. Finally, First Trust Advisors LP purchased a new position in LifeStance Health Group during the 4th quarter worth $4,535,000. 85.50% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

LFST has been the subject of a number of research reports. KeyCorp initiated coverage on shares of LifeStance Health Group in a report on Tuesday, April 8th. They issued an “overweight” rating and a $9.00 target price for the company. BTIG Research initiated coverage on LifeStance Health Group in a research report on Friday. They issued a “buy” rating and a $8.00 price target on the stock. UBS Group raised LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $8.50 price objective for the company in a research report on Tuesday, May 27th. Finally, Canaccord Genuity Group began coverage on LifeStance Health Group in a research note on Thursday, April 3rd. They issued a “buy” rating and a $8.00 target price on the stock. One investment analyst has rated the stock with a sell rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, LifeStance Health Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $8.42.

Insider Transactions at LifeStance Health Group

In other LifeStance Health Group news, insider Ujjwal Ramtekkar sold 16,000 shares of the business’s stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $5.94, for a total transaction of $95,040.00. Following the sale, the insider directly owned 113,435 shares in the company, valued at approximately $673,803.90. The trade was a 12.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 6.60% of the company’s stock.

LifeStance Health Group Price Performance

LFST stock opened at $4.17 on Tuesday. The firm has a 50 day moving average of $5.09 and a 200-day moving average of $6.42. The company has a market cap of $1.62 billion, a price-to-earnings ratio of -41.70 and a beta of 1.16. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 0.19. LifeStance Health Group, Inc. has a 12-month low of $4.09 and a 12-month high of $8.61.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.